Influence of pinealectomy and long-term melatonin administration on bone metabolism in orchidectomized rats;Wpływ pinealektomii i długotrwałego podawania melatoninyna metabolizm kostny u szczurów poddanych orchidektomii

Endokrynologia Polska

Volumn 57, Issue 1, 2006, Pages 7-14

  Ostrowska, Zofia ^a   Kos Kudła, Beata ^a   Świȩtochowska, Elzbieta ^a   Marek, Bogdan ^a   Kajdaniuk, Dariusz ^a   Nowak, Mariusz ^a   Kobielski, Andrzej ^b  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

^b Burns Ward   (Poland)

Author keywords

ICTP; Melatonin; Orchidectomy; PICP; Pinealectomy; Rats

Indexed keywords

MELATONIN;

ANIMAL; ARTICLE; BONE; MALE; METABOLISM; ORCHIECTOMY; PINEAL BODY; RAT; WISTAR RAT;

ANIMALS; BONE AND BONES; MALE; MELATONIN; ORCHIECTOMY; PINEAL GLAND; RATS; RATS, WISTAR;

EID: 33751062479     PISSN: 0423104X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Badurski J, Sawicki A, Boczon S. Osteoporoza. Osteoprint 1994.
2. Galus K. Choroby metaboliczne kosci. Med. Tur Pres International, Warszawa 1995.
3. Głogowska-Szelag J, Kos-Kudła B. Osteoporoza u mezczyzn. Twój Mag Med-Osteoporoza 2001; 6 (37): 25-30.
4. Nakade O, Koyama H, Ariji H i wsp. Melatonin stimulates proliferation and type I collagen synthesis in human cells in vitro. J Pineal Res 1999; 27: 106-110. (Pubitemid 29440990)
5. Roth JA, Kim BG, Lin WL i wsp. Melatonin promotes osteoblast differentiation and bone formation. J Biol Chem 1999; 274: 22041-22047.
6. Cardinali DP, Ladizesky MG, Boggio V i wsp. Melatonin effects on bone: experimental facts and clinical perspectives. J Pineal Res 2003; 34: 81-87. (Pubitemid 36255915)
7. Ostrowska Z, Kos-Kudła B, Marek B i wsp. Perspektywy stoso-wania melatoniny w profilaktyce i leczeniu osteoporozy. Przegl Menop 2003; 5: 43-46.
8. Ostrowska Z, Kos-Kudła B, Marek B i wsp. The relationship between daily profile of chosen biochemical markers of bone metabolism and melatonin and other hormone secretion in rats under physiological conditions. Neuroendocrinol Lett 2002; 23: 417-425. (Pubitemid 36050018)
9. Ostrowska Z, Kos-Kudła B, Marek B i wsp. Influence of lighting conditions on daily rhytmicity of bone metabolism in rats and possible involvement of melatonin and other hormones in this process. Endocr Regul 2003; 37: 163-174. (Pubitemid 37413359)
10. Ostrowska Z, Kos-Kudła B, Nowak M i wsp. The relationship between bone metabolism, melatonin and other hormones in sham-operated and pinealectomized rats. Endocr Regul 2003; 37: 211-224. (Pubitemid 38175991)
11. Ladizesky MG, Cutrera RA, Boggio V i wsp. Effect of melato-nin on bone metabolism in ovariectomized rats. Life Sci 2001; 70: 557-565. (Pubitemid 34066523)
12. Ostrowska Z, Kos-Kudła B, Swietochowska E i wsp. Assessment of the relationship between dynamic pattern of nighttime levels of melatonin and chosen biochemical markers of bone metabolism in a rat model of postmenopausal osteoporosis. Neuroendocrinol Lett 2001; 22: 131-138.
13. Ostrowska Z, Kos-Kudła B, Marek B i wsp. The influence of pinealectomy and melatonin administration on the dynamic pattern of biochemical markers of bone metabolism in experimental osteoporosis in the rat. Neuroendocrinol Lett 2002; 23 (supl. 1): 104-109. (Pubitemid 34495392)
14. Ladizesky MG, Boggio V, Albornoz LE i wsp. Melatonin increases oestradiol-induced bone formation in ovariectomized rats. J Pineal Res 2003; 34: 143-151. (Pubitemid 36255923)
15. Karasek M, Reiter RJ. Melatonin and aging. Neuroendocrinol Lett 2002; 23 (supl. 1): 14-16. (Pubitemid 34495375)
16. Schmidt HA, Requintina PJ, Oxenkurg GF i wsp. Calcium, calcification, and melatonin biosynthesis in the human pineal gland: a postmortem study into age-related factors. J Pineal Res 1994; 16: 178-183.
17. Sandyk R, Anastasiadis PG, Annimos PA i wsp. Is postmeno-pausal osteoporosis related to pineal gland functions? Int J Neurosc 1992; 62: 215-225.
18. Ostrowska Z, Kos-Kudła B, Marek B i wsp. Assessment of the relationship between circadian variations of salivary melato-nin levels and type I collagen metabolism in postmenopausal obese women. Neuroendocrinol Lett 2001; 22: 121-127. (Pubitemid 32396390)
19. Ostrowska Z, Kos-Kudła B, Marek B i wsp. Gestosc mineralna kosci a dobowe stezenia melatoniny, osteoprotegeryny i RANKL u otyłych kobiet po menopauzie. 35 Zjazd Towarzy-stwa Internistów Polskich, 9-12 wrzesnia 2004, Katowice. Pol Arch Med Wewn 2004; 112 (supl. 1): 413.
20. Cohen M, van Heusden AM, Verdok HER i wsp. Melatonin//noretisterone contraception. W: Touitou Y, Arendt J, Pevet P, (red.). Melatonin and the pineal gland-from basic science to clinical application Elsevier, Amsterdam 1993; 339-345.
21. th European Congress of Endocrinology, Lyon, France, 26-30 April 2003 (Abstract Book, P0556).
22. Kuszak J, Rodin M. A new technique of pinealectomy for adult rats. Experientia (Basel) 1977; 33: 283-284. (Pubitemid 8036307)
23. Vanderschuren D, van Herck E, Suiker AM i wsp. Bone and mineral metabolism in aged male rats: short and long term effects on androgen deficiency. Endocrinology 1992; 130: 2906-2916.
24. Danielsen CC, Mosekilde L, Andreassen TT. Long-term effect of orchidectomy on cortical bone from rat femur: bone mass and mechanical properties. Calcif Tissue Int 1992; 50: 167-174.
25. Suda T, Nakamura I, Jimi E i wsp. Regulation of osteoclast function. J Bone Miner Res 1997; 12: 869-879.
26. 2 or parathyroid hormone in the microenvironment of bone. Biochem Biophys Res Commun 1998; 246: 337-41. (Pubitemid 28412599)
27. Yasuda H, Shima N, Nakagawa N i wsp. Identification of osteo-clastogenesis-inhibitory factor (OCIF) and osteoprotegerin (OPG): A mechanism by which OPG/OCIF inhibits osteocla-stogenesis in vitro. Endocrinology 1998; 139: 1329-1337. (Pubitemid 28510154)
28. Hsu H, Lacey DL, Dnstan CR i wsp. Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand. Proc Natl Acad Sci USA 1999; 96: 3540-3545. (Pubitemid 29168945)
29. Kus I, Sarsilmaz M, Ogeturk M i wsp. Ultrastructural interrelationship between the pineal gland and the testis in the male. Arch Androl 2000; 45: 119-124.
30. Karasek M. Szyszynka i melatonina. PWN, Warszawa-Łódz 1997.
31. Zisapel N, Anis Y. Impact of circulating testosterone on iodo-melatonin binding sites in the male rat brain. Mol Cell Endo-crinol 1988; 60: 119-126. (Pubitemid 19005697)
32. Vanecek J, Kosar E, Vorlicek J. Daily changes in melatonin binding sites and the effect of castration. Mol Cell Endocrinol 1990; 22: 165-170. (Pubitemid 20345387)
33. Pavlikov SA, Isachenkov VA. Effect of androgens (testosterone, 5 alpha-dihydrotestosterone, 3 alpha activity of N-acetylo-serotonin metyltransferase and hydroxyindole O-metyltrans-ferase in the pineal body of castrated rats. Probl Endokrinol (Mosk) 1979; 25: 72-77. (Pubitemid 9248511)
34. Morgan PJ, Barret P, Howell E i wsp. Melatonin receptors: localization, molecular pharmacology and physiological significance. Neurochem Int 1994; 24: 101-146. (Pubitemid 24061864)
35. Kayoma H, Nakade O, Takada Y i wsp. Melatonin at phar-macologic doses increases bone mass by suppressing resorp-tion trough down-regulation of the RANKL-mediated oste-oclast formation and activation. J. Bone Mineral Res 2002; 17: 1219-1229. (Pubitemid 34680498)